Sophia Genetics SA logo

Sophia Genetics SA (90B)

Market Closed
3 Jun, 06:03
XFRA XFRA
4. 1400
-0.1
-2.36%
- Market Cap
- P/E Ratio
- Div Yield
70 Volume
-1.11 Eps
4.24
Previous Close
Add Transaction
Day Range
4.14 4.14
Year Range
2.44 4.64
Want to track 90B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

90B closed today lower at €4.14, a decrease of -2.36% from yesterday's close, completing a monthly decrease of -3.72% or -€0.16. Over the past 12 months, 90B stock gained 6.15%.
90B is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2026, exceeded the consensus estimates by 0.24%. On average, the company has surpassed earnings expectations by 0.22%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

90B Chart

SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript

SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript

SOPHiA GENETICS SA (SOPH) Q1 2026 Earnings Call Transcript

Seekingalpha | 4 weeks ago
SOPHiA GENETICS (NASDAQ:SOPH) & Hims & Hers Health (NYSE:HIMS) Financial Comparison

SOPHiA GENETICS (NASDAQ:SOPH) & Hims & Hers Health (NYSE:HIMS) Financial Comparison

Hims and Hers Health (NYSE: HIMS - Get Free Report) and SOPHiA GENETICS (NASDAQ: SOPH - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings. Valuation and Earnings This table compares

Defenseworld | 2 months ago
SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript

SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript

SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 months ago

Sophia Genetics SA (90B) FAQ

What is the stock price today?

The current price is €4.1400.

On which exchange is it traded?

Sophia Genetics SA is listed on XFRA.

What is its stock symbol?

The ticker symbol is 90B.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Sophia Genetics SA ever had a stock split?

No, there has never been a stock split.

Sophia Genetics SA Profile

Health Care Technology Industry
Healthcare Sector
Jurgi Camblong CEO
XFRA Exchange
CH1125843347 ISIN
CH Country
423 Employees
- Last Dividend
- Last Split
23 Jul 2021 IPO Date

Overview

SOPHiA GENETICS SA stands out as a pioneering cloud-native software technology company within the healthcare sector, specializing in the complex analysis of data to derive meaningful insights. Founded in 2011 with its headquarters in Rolle, Switzerland, SOPHiA GENETICS has quickly become a notable entity for leveraging cloud technology to facilitate advancements in healthcare analytics. The company's reach spans a global network, providing services through its direct sales force, distributors, and industry collaborators across various regions including Switzerland, France, Italy, the rest of Europe, North America (with a specific focus on the United States), Latin America, and the Asia-Pacific region. By marrying innovative technology with comprehensive data analysis, SOPHiA GENETICS is redefining the approach to healthcare diagnostics and research, making significant strides toward the future of personalized medicine and enhanced patient care.

Products and Services

  • SOPHiA DDM Platform
  • A sophisticated cloud-native software platform designed by SOPHiA GENETICS to offer unparalleled analysis of multimodal data sets and diagnostic modalities. This platform serves as the foundation for generating actionable insights, propelling the use of data-driven decision-making in healthcare. Aimed at transforming raw data into meaningful information, the SOPHiA DDM Platform is crucial for hospitals, laboratories, and biopharmaceutical companies striving toward the advancement of personalized medicine and better health outcomes.

  • Related Solutions, Applications, Products, and Services
  • In addition to the SOPHiA DDM platform, SOPHiA GENETICS offers a comprehensive range of related solutions, applications, products, and services tailored to meet the diverse needs of the healthcare industry. These offerings are designed to enhance the capabilities of the SOPHiA DDM platform, ensuring that clients have access to a full suite of tools for diagnostics, research, and development. The expansive availability of these sophisticated solutions demonstrates SOPHiA GENETICS's commitment to supporting healthcare professionals and researchers in their quests to uncover groundbreaking findings and improve patient care across the globe.

Contact Information

Address: Rue du Centre 172
Phone: 41 21 694 10 60